ImmusanT, Inc.
Biotechnology company · Cambridge, Massachusetts, United States
ImmusanT, Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2010. It has reported private securities offerings to the US SEC, most recently $20 million sold in a notice filed in 2017.
ImmusanT at a glance
What does ImmusanT do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $19.9 million sold (2017).
Frequently asked questions about ImmusanT
Where is ImmusanT headquartered?
ImmusanT, Inc. is headquartered in Cambridge, Massachusetts, United States.
What does ImmusanT do?
ImmusanT, Inc. is a biotechnology company.
When was ImmusanT founded?
The earliest incorporation on record for ImmusanT, Inc. is in 2010, according to public company registers.
Similar companies
- Editas Medicine, Inc.Cambridge, Massachusetts, United States
- Moderna, Inc.Cambridge, Massachusetts, United States
- Relay Therapeutics, Inc.Cambridge, Massachusetts, United States
- Beam Therapeutics Inc.Cambridge, Massachusetts, United States
- Genzyme CorpCambridge, Massachusetts, United States
- Neutrolis Inc.Cambridge, Massachusetts, United States
- Biogen Inc.Cambridge, Massachusetts, United States
- Black Diamond Therapeutics, Inc.Cambridge, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences